Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 118

1.

HPV self-testing and cervical cancer screening coverage.

Gravitt PE, Rositch AF.

Lancet Oncol. 2014 Feb;15(2):128-9. doi: 10.1016/S1470-2045(13)70605-3. Epub 2014 Jan 14. No abstract available.

PMID:
24433681
2.

ACP Journal Club. Review: Self-collected samples are less accurate for HPV testing than clinician-collected samples.

Frank DA, Marrazzo J.

Ann Intern Med. 2014 Aug 19;161(4):JC11. doi: 10.7326/0003-4819-161-4-201408190-02011. No abstract available.

PMID:
25133378
3.

Primary screening for high risk HPV by home obtained cervicovaginal lavage is an alternative screening tool for unscreened women.

Nobbenhuis MA, Helmerhorst TJ, van den Brule AJ, Rozendaal L, Jaspars LH, Voorhorst FJ, Verheijen RH, Meijer CJ.

J Clin Pathol. 2002 Jun;55(6):435-9.

4.

Results of a community-based cervical cancer screening pilot project using human papillomavirus self-sampling in Kampala, Uganda.

Ogilvie GS, Mitchell S, Sekikubo M, Biryabarema C, Byamugisha J, Jeronimo J, Miller D, Steinberg M, Money DM.

Int J Gynaecol Obstet. 2013 Aug;122(2):118-23. doi: 10.1016/j.ijgo.2013.03.019. Epub 2013 Jun 2.

PMID:
23731506
5.

Time to consider HPV testing in cervical screening.

Cuzick J.

Ann Oncol. 2001 Nov;12(11):1511-4. Review. No abstract available.

6.

Is it time to introduce HPV self-sampling for primary cervical cancer screening?

Petignat P, Vassilakos P.

J Natl Cancer Inst. 2012 Feb 8;104(3):166-7. doi: 10.1093/jnci/djr544. Epub 2012 Jan 23. No abstract available.

7.

The role of self-collection devices for cytology and human papillomavirus DNA testing in cervical cancer screening.

Bidus MA, Zahn CM, Maxwell GL, Rodriguez M, Elkas JC, Rose GS.

Clin Obstet Gynecol. 2005 Mar;48(1):127-32. Review. No abstract available.

PMID:
15725865
8.

HPV testing in cervical screening.

Cuzick J.

Pharmacoepidemiol Drug Saf. 2001 Jan-Feb;10(1):33-6. Review. No abstract available.

PMID:
11417064
9.

Screening for cervical cancer.

Ronco G, Meijer CJ, Cuzick J, Giorgi-Rossi P, Peto J, Segnan N, Dillner J.

Ann Intern Med. 2012 Apr 17;156(8):604-5; author reply 605-6. doi: 10.7326/0003-4819-156-8-201204170-00011. No abstract available.

PMID:
22508738
10.

HPV screening for cervical cancer in rural India.

Suba EJ, Cibas ES, Raab SS.

N Engl J Med. 2009 Jul 16;361(3):304; author reply 306. doi: 10.1056/NEJMc090939. No abstract available.

11.

HPV DNA testing for cervical cancer screening. FIGO 26th Annual Report on the Results of Treatment in Gynecological Cancer.

Wright TC Jr.

Int J Gynaecol Obstet. 2006 Nov;95 Suppl 1:S239-46. Review. No abstract available.

PMID:
17161163
12.

Effect of vaginal self-sampling on cervical cancer screening rates: a community-based study in Newfoundland.

Duke P, Godwin M, Ratnam S, Dawson L, Fontaine D, Lear A, Traverso-Yepez M, Graham W, Ravalia M, Mugford G, Pike A, Fortier J, Peach M.

BMC Womens Health. 2015 Jun 10;15:47. doi: 10.1186/s12905-015-0206-1.

13.

Comparison of self-collected vaginal, vulvar and urine samples with physician-collected cervical samples for human papillomavirus testing to detect high-grade squamous intraepithelial lesions.

Sellors JW, Lorincz AT, Mahony JB, Mielzynska I, Lytwyn A, Roth P, Howard M, Chong S, Daya D, Chapman W, Chernesky M.

CMAJ. 2000 Sep 5;163(5):513-8.

14.

Detection of carcinogenic human papillomavirus in specimens collected with a novel self-sampling device.

Castle PE, Aftab A, Saint-Jean G, Mendez L.

J Clin Microbiol. 2006 Jun;44(6):2158-9.

15.

Design and methods of the evaluation of an HPV-based cervical cancer screening strategy in Mexico: The Morelos HPV Study.

Flores Y, Shah K, Lazcano E, Hernández M, Bishai D, Ferris DG, Lörincz A, Hernández P, Salmerón J; Morelos HPV Study Collaborators.

Salud Publica Mex. 2002 Jul-Aug;44(4):335-44.

PMID:
12216521
16.
17.

HPV primary screening for cervical cancer: more pain than protection.

Davey DD, Armenti CA.

Diagn Cytopathol. 2000 Jun;22(6):333-5. No abstract available.

PMID:
10820524
18.

Forgotten implications of HPV positivity for the majority of females: a clinical perspective.

Tidy J.

Cytopathology. 2002 Oct;13(5):263-6. Review. No abstract available.

PMID:
12421441
19.

Screening based on papillomavirus detection: too many false alarms.

[No authors listed]

Prescrire Int. 2010 Aug;19(108):178-9.

PMID:
20939456
20.

[HPV test replaces Pap test in Uppsala].

Olovsson M, Aarnio R, Rezapour M, Segeblad B, Sjöö EL, Wilander E.

Lakartidningen. 2013 Mar 26-Apr 9;110(13-14):695-6. Swedish. No abstract available.

PMID:
23634626
Items per page

Supplemental Content

Write to the Help Desk